Cosmetic ingredients

22/11/2026 9 min read

Silicone elastomer (dimethicone/vinyl dimethicone crosspolymer)

Dimethicone/vinyl dimethicone crosspolymer is a silicone elastomer often found in primers, foundations and sunscreens. This article checks it against verified sources: its definition, how it is made and the impurities to ask suppliers about, the concentrations companies have reported, the CIR safety conclusion, the D4/D5/D6 rules for exports to the EU, its status in the ASEAN annexes and the limits of the “pore-blurring” claim.

Silicone elastomer (dimethicone/vinyl dimethicone crosspolymer)
Illustrative photo: a flat-top makeup brush loaded with beige foundation, resting on a swatch of foundation swept across a gray-white background; no people, no text, no branding — a general illustration for cream makeup products, not a photo of the ingredient (the ingredient is usually a gel swollen in silicone oil).

Dimethicone/vinyl dimethicone crosspolymer is a crosslinked network silicone (silicone elastomer): dimethicone chains are linked to one another through vinyl dimethicone. According to the CIR (Cosmetic Ingredient Review, US) Expert Panel, it has the highest number of reported uses in the group of 62 dimethicone crosspolymers, mainly in leave-on products, and was concluded to be safe in the present practices of use and concentration described.

1. What is dimethicone/vinyl dimethicone crosspolymer?

The INCI definition quoted in the CIR report: “a copolymer of dimethylpolysiloxane crosslinked with vinyl dimethylpolysiloxane”; its listed function is viscosity increasing agent for non-aqueous systems (viscosity increasing agent – nonaqueous). As a crosslinked polymer, it has no defined molecular formula or molecular weight. The CIR report gives no CAS number; on PubChem, a substance record supplied by a depositor links the INCI name to CAS 243137-53-3 — this should be checked against the supplier’s documentation.

CIR describes the dimethicone crosspolymers as silicone elastomers, typically supplied to cosmetic manufacturers as swollen gels containing an oil, for example a silicone oil such as dimethicone; the substances in the group are insoluble in water and, depending on their structure, range from liquids to elastic solids. A supplier data sheet quoted in the report lists commercial blends containing 4–30% dimethicone/vinyl dimethicone crosspolymer. A formula should therefore state clearly whether a percentage refers to the commercial blend or to the polymer.

Unlike dimethicone (in Vietnamese), a linear liquid silicone, and PEG-12 dimethicone, a PEG-modified, water-soluble silicone, the chains here are joined into a three-dimensional network.

2. Manufacturing and impurities to check

According to CIR, most dimethicone crosspolymers are made by hydrosilylation: the silicon–hydrogen (Si–H) bonds on a precursor silicone chain add across the vinyl double bonds of the crosslinking agent, usually requiring a catalyst such as platinum. Because this is an addition reaction, the expected by-products are limited to the starting materials, especially the catalyst. For example, the precursor is made by copolymerizing dimethylsiloxane units with methylhydrogen siloxane.

  • Heavy metals: a supplier data sheet quoted by CIR states that blends containing this ingredient have heavy metals below 20 ppm and arsenic below 2 ppm.
  • Residual monomers and catalyst: the CIR Panel noted the lack of data, but considered that residual levels are likely very low or undetectable because they are trapped in the silicone network or evaporate; the Panel recommended that suppliers continue keeping them at the lowest reasonably achievable levels.
  • Cyclic silicones: CIR has no D4 or D5 data for this ingredient specifically. For two other crosspolymers in the group, supplied as blends in cyclopentasiloxane or isododecane, suppliers reported platinum below 25 ppm and cyclotetrasiloxane at a maximum of 0.1% and below 1%, respectively. Because the gel may be made up in dimethicone or in cyclic silicones, the COA should state the carrier oil and the D4, D5 and D6 content for each lot.

3. Role in formulas and current evidence

A PubMed search (November 22, 2026, keywords “vinyl dimethicone”, “dimethicone crosspolymer”, “silicone elastomer”) found no human efficacy trials for this ingredient specifically; it appears only as one component of multi-ingredient formulas. Level of evidence: limited. The roles below are mainly formulation functions.

SourceContent as reported by the sourceRelevance
CIR, 2012 (Becker et al., 2014)Function of the ingredient: viscosity increasing agent for non-aqueous systems; the group as a whole is used as absorbents, film formers, emollients, slip modifiers and surface modifiersDirect (definition, use, safety)
Starch et al., 2003Silicone elastomers without functional groups provide thickening; PEG-modified versions additionally emulsify water-in-silicone systems; the test samples were dispersions in cyclopentasiloxaneIndirect (PEG-modified relatives); the first author is affiliated with a silicone company
Aliyar & Schalau, 2015Review: swollen crosslinked silicone elastomer networks are a new technology for topical excipients; hydrophobicity, adhesion and sensory properties are inherent properties of siliconesIndirect (pharmaceutical excipients); the authors are affiliated with a silicone company
Lai et al., 2025Ray-tracing simulation (validated): finer skin-surface microstructure increases diffuse reflection, producing a more pronounced “soft focus” effectOptical principle, did not test this ingredient; includes industry co-authors
Yoon et al., 2020Porous PMMA particles coated with TiO2 increased diffuse reflection by up to 160% compared with the inorganic particles alone, giving a soft-focus effectDifferent particles, not a silicone; includes industry co-authors

About the “pore-blurring” claim. Soft focus is an optical phenomenon: light is diffusely scattered, so the surface looks smoother (Lai et al., 2025; Yoon et al., 2020). We found no peer-reviewed study measuring this effect for dimethicone/vinyl dimethicone crosspolymer specifically. If a related claim is used, it should be presented as a visible effect on the surface, substantiated by imaging or measurements on the finished product, and not described as a change to the pores.

4. Reported concentrations and product types

The CIR report compiles the frequency of use from the FDA Voluntary Cosmetic Registration Program (2012) and the maximum concentrations reported by companies in a survey by the US Personal Care Products Council (2012). These are reported levels, not recommendations; the report does not state whether the figures refer to the polymer or to the commercial blend.

CategoryNumber of usesMaximum reported concentration
Total4570.003–46%
Leave-on4440.003–46%
Rinse-off130.06–37%
Eye area590.02–33%
Possible incidental ingestion (lip products)90.02–3%
Sprays / powders with possible inhalation24 / 230.2–0.5% / 0.2–46%
Hair products (non-coloring)140.2–3%
Mucous membranes100.02–3%
Nail products—0.003%
Baby products1not reported

5. Safety

CIR conclusion. The final report released on September 28, 2012 (published in Int J Toxicol in 2014) concluded that the 62 dimethicone crosspolymers, including this ingredient, “are safe in the present practices of use and concentration described in this safety assessment”. The CIR Quick Reference Table lists a safe conclusion at use levels of 0.003–46%. Data specific to this ingredient (submitted by industry, unpublished):

  • Skin irritation (rabbits): a product containing about 24% of this ingredient in dimethicone, applied under occlusion to intact and abraded skin (6 animals): primary irritation index 1.42, classified by the authors as mildly irritating.
  • Sensitization: in guinea pigs (5 per sex), the product at about 24% was not sensitizing. In humans: two modified human repeat insult patch tests (HRIPT; n = 107) with a facial lotion containing 1% of this ingredient were not sensitizing.
  • Genotoxicity: the product at about 24% in dimethicone (5,000 µg/plate) was not mutagenic in the Ames test.
  • Data gaps: the Panel noted that this group lacks data on absorption, repeated-dose toxicity, reproductive and developmental toxicity, and carcinogenicity, but was not concerned because these are large polymers that do not penetrate the skin, and the silicone backbone is stable under conditions of use.
  • Inhalation (powders, sprays): the Panel considered that most particles are larger than the respirable range or are agglomerated in the formula, so incidental inhalation is not a significant route of exposure.
  • Allergy: a PubMed search (November 22, 2026) found no case reports of allergic contact dermatitis for this ingredient specifically; the absence of reports does not mean it cannot occur.
  • Pregnant and breastfeeding women: human data are insufficient; consult a doctor.

6. Perspective for brand owners (B2B)

  • ASEAN regulations: a search of Annexes II, III, VI (version 2026-1, June 22, 2026) and VII (version 2025-2) by ingredient name, the strings “crosspolymer”, “vinyl dimethicone”, “methicone”, “siloxane”, “silicone”, “elastomer” and CAS 243137-53-3 found no entry for this ingredient, so there is no specific concentration limit or label warning. Annex II contains Ref 1388 “Octamethylcyclotetrasiloxane; D4” — this needs attention when the gel is made up in a cyclic silicone or contains residues.
  • Products exported to the EU: Regulation (EU) 2024/1328 (REACH Annex XVII, entry 70) prohibits placing on the market mixtures containing D4, D5 or D6 at 0.1% by weight or more (for each substance); for D4 and D5 in rinse-off cosmetics, this applies after January 31, 2020; for all other cosmetic cases, after June 6, 2027. The regulation provides exemptions for residual D4, D5 and D6 from silicone polymers in certain uses (adhesives, coatings, medical devices…), but cosmetics are not on this list. See also the article on cyclopentasiloxane (D5) (in Vietnamese).
  • Raw material documentation: request the full INCI of the blend (polymer and carrier oil), the polymer percentage, and a COA covering D4, D5, D6 and heavy metals.
  • Formulation (practical experience; test in small batches): the material is insoluble in water and goes into the oil phase or silicone phase; in emulsions it is usually added at the end with moderate stirring, avoiding high-shear homogenization once viscosity has built; count the carrier oil toward the total oil phase. According to Starch et al. (2003), elastomers without hydrophilic groups mainly thicken; it is the PEG-modified versions that are described as emulsifiers for water-in-silicone systems.
  • Claims: “smooth, dry feel” and “the skin surface looks instantly smoother” may be used once sensory testing and imaging have been done on the finished product. Avoid “tightens pores”, “erases wrinkles”, “non-comedogenic” without testing, and “silicone-free”.

Butter-C uses silicone elastomers in some contract-manufactured formulas for primers, foundations and sunscreens; the proportion and skin feel are finalized through testing on samples.

Frequently asked questions

Is dimethicone/vinyl dimethicone crosspolymer a silicone?

Yes. It is a crosslinked dimethicone network; products containing it must not be labeled “silicone-free”.

Does this ingredient clog pores or cause breakouts?

The sources searched contain no comedogenicity studies for this ingredient specifically. To state “non-comedogenic”, the finished product needs to be tested.

Do silicone elastomers make pores smaller?

There are no data showing that the ingredient acts on pore structure; “soft focus” is an optical effect on the surface.

Can it be used around the eyes?

CIR lists 59 uses in eye-area products, reported at up to 33%, within the safe conclusion. If it gets into the eyes, rinse with clean water.

Can pregnant women use products containing this ingredient?

Human data are insufficient; consult a doctor.

References

  1. Cosmetic Ingredient Review. Safety Assessment of Dimethicone Crosspolymers as Used in Cosmetics (Final Report for public distribution, released September 28, 2012). https://www.cir-safety.org/sites/default/files/Dimeth092012rep.pdf
  2. Becker LC et al. Safety Assessment of Dimethicone Crosspolymers as Used in Cosmetics. Int J Toxicol. 2014. PMID 24861370
  3. Cosmetic Ingredient Review. Quick Reference Table (quick reference table of CIR conclusions). https://cir-safety.org/sites/default/files/Safe-122015posted033016.pdf
  4. Starch MS et al. Beyond rheology modification: hydrophilically modified silicone elastomers provide new benefits. J Cosmet Sci. 2003. PMID 12715095
  5. Aliyar H et al. Recent developments in silicones for topical and transdermal drug delivery. Ther Deliv. 2015. PMID 26228774
  6. Lai PY et al. Study of diffuse scattering on facial surface using ray tracing approach. Sci Rep. 2025. PMID 40221504
  7. Yoon J et al. Highly Scattering Hierarchical Porous Polymer Microspheres with a High-Refractive Index Inorganic Surface for a Soft-Focus Effect. Polymers (Basel). 2020. PMID 33092196
  8. European Commission. Commission Regulation (EU) 2024/1328 of 16 May 2024 amending Annex XVII to Regulation (EC) No 1907/2006 (REACH) as regards D4, D5 and D6. Official Journal of the European Union. 2024. https://publications.europa.eu/resource/cellar/e54ebba3-13e7-11ef-a251-01aa75ed71a1.0006.03/DOC_1

Get started

Talk to us about the product you plan to launch

Please send us your product direction and expected quantities. Our team will get back to you during business hours.

Công ty cổ phần Dược mỹ phẩm Butter-C · Business registration no. 0108681386 (Hanoi Department of Planning and Investment, 03/04/2019)
Head office: Huu Le village, Dai Thanh commune, Hanoi · Factory: Thanh Oai Industrial Cluster, Binh Minh commune, Hanoi, Vietnam
Hotline 0967 176 511 · [email protected] · privacy policy
Product catalog →